Global Coronary Artery Bypass Grafts (CABG) Market Growth (Status and Outlook) 2025-2031

Global Coronary Artery Bypass Grafts (CABG) Market Growth (Status and Outlook) 2025-2031

The global Coronary Artery Bypass Grafts (CABG) market size is predicted to grow from US$ 139 million in 2025 to US$ 191 million in 2031; it is expected to grow at a CAGR of 5.4% from 2025 to 2031.

Coronary artery bypass surgery, also known as coronary artery bypass graft (CABG) surgery, and colloquially heart bypass or bypass surgery, is a surgical procedure to restore normal blood flow to an obstructed coronary artery.

Global Coronary Artery Bypass Grafts (CABG) key players include Medtronic, Getinge Group, LivaNova, Terumo, Boston Scientific, etc. Global top five manufacturers hold a share about 65%.

North America is the largest market, with a share over 35%, followed by Europe and Asia-Pacific, both have a share about 55 percent.

In terms of product, Saphenous Vein Grafts is the largest segment, with a share about 70%. And in terms of application, the largest application is Traditional CABG, followed by Nontraditional CABG.

LPI (LP Information)' newest research report, the “Coronary Artery Bypass Grafts (CABG) Industry Forecast” looks at past sales and reviews total world Coronary Artery Bypass Grafts (CABG) sales in 2024, providing a comprehensive analysis by region and market sector of projected Coronary Artery Bypass Grafts (CABG) sales for 2025 through 2031. With Coronary Artery Bypass Grafts (CABG) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Coronary Artery Bypass Grafts (CABG) industry.

This Insight Report provides a comprehensive analysis of the global Coronary Artery Bypass Grafts (CABG) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Coronary Artery Bypass Grafts (CABG) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Coronary Artery Bypass Grafts (CABG) market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Coronary Artery Bypass Grafts (CABG) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Coronary Artery Bypass Grafts (CABG).

This report presents a comprehensive overview, market shares, and growth opportunities of Coronary Artery Bypass Grafts (CABG) market by product type, application, key players and key regions and countries.

Segmentation by Type:
Saphenous Vein Grafts
Internal Thoracic Artery Grafts
Other

Segmentation by Application:
Traditional CABG
Nontraditional CABG

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Medtronic
Getinge Group
LivaNova
Terumo
Boston Scientific
Stryker
Edwards Lifesciences
Genesee Biomedical
Karl Storz GmbH

Please note: The report will take approximately 2 business days to prepare and deliver.